`
`BEFORE THE PATENT TRJAL AND APPEAL BOARD
`
`SAW AI USA, INC. and
`SA WAI PHARMA CEUTICAL CO., LTD.
`Petitioners,
`
`V.
`
`BIOGEN MA, INC.
`
`Patent Owner.
`
`U.S. Patent No. 8,399,514 to Lukashev et al.
`
`
`
`Issue Date: March 19, 2013
`
`Title: Treatment for Multiple Sclerosis
`
`
`
`Inter Partes Review No.: IPR2019-00789
`
`PETITIONER'S POWER OF A TIORNEY
`
`r
`
`Mai/Stop "PATENT BOARD"
`
`
`Patent Trial and Appeal Board
`
`
`U.S. Patent and Trademark Office
`P.0.Box1450
`
`Alexandria, VA 22313-1450
`
`US_ 137920 I 09v l _385667-00004
`
`
`
`PETITIONER'S POWER OF ATTORNEY
`
`Pursuantto 37 C.F.R. § 42. l0(b), Petitioner Sawai USA, Inc. having a
`
`principal place of business at 11 Morgan, Irvine, CA 92618, USA, hereby appoints
`
`the following practitioners as its attorneys to transact all business in the United
`
`States Patent & Trademark Office Association with any inter partes review of U.S.
`
`Patent No 8,399,514:
`
`Lead Counsel
`Brian Sodikoff
`Reg. No. 54,697
`Katten Muchin Rosenman LLP
`525 West Monroe Street
`Chicago, IL 60661-3693
`brian. sodikoff@kattenlaw.com
`
`Back-up Counsel
`Christopher B. Ferenc
`Reg. No. 59,365
`Katten Muchin Rosenman LLP
`2900 K Street NW
`North Tower- Suite 200
`Washington, DC 20007-5118
`christopher. ferenc@kattenlaw.com
`
`and all practitioners associated with Customer Number 27160.
`
`I have the authority to execute this document on behalf of Sawai USA, Inc.
`
`~<~
`Na~kEN~o .SA-wA)
`.f>r-e~ 1 J e,vit
`Title:
`Date: February ~
`' 2019
`
`US_ 137920 I 09v I _385667-00004
`
`